Abstract
Prescribing for older patients presents several challenges. Older people often suffer from two or more chronic diseases (multimorbidity) and therefore use a greater number of medications compared to other age groups. As a result, they are more susceptible polypharmacy, and associated drug-related problems, including potentially inappropriate medication (PIM), drug ineffectiveness, drug interactions, and adverse drug events (Nobili et al., 2011; Aggarwal et al., 2020). Consequently, optimizing drug therapy is a crucial part of caring for an elderly individual. This is increasingly important given the rising number of elderlies across countries in the coming years, with one in 6 of the world’s population over 60 by 2050 and the associated resource implications (World Health Organization, 2021).
| Original language | English |
|---|---|
| Article number | 941813 |
| Number of pages | 6 |
| Journal | Frontiers in Pharmacology |
| Volume | 13 |
| DOIs | |
| Publication status | Published - 1 Jun 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- elderly
- drug safety
- assessment
- health policy
Fingerprint
Dive into the research topics of 'Evidence for assessing drug safety and drug use in older people'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver